PreprintCited by 55Antimicrobial Peptides and ActivitiesComputational Drug Discovery MethodsChemical Synthesis and Analysis

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

ProT-Diff: A Modularized and Efficient Approach to De Novo Generation of Antimicrobial Peptide Sequences through Integration of Protein Language Model and Diffusion Model

Open access
Wang, Xue-Fei, Tang, Jing-Ya, Liang, Han, Sun, Jing, Dorje, Sonam, Peng, Bo, Ji, Xu-Wo, Li, Zhe, Zhang, Xian-En, Wang, Dian-Bing·2024·Advanced Science

Preprint — published as 10.1002/advs.202406305

Abstract

Antimicrobial Peptides (AMPs) represent a promising class of antimicrobial agents crucial for combating antibiotic-resistant pathogens. Despite the emergence of deep learning approaches for AMP discovery, there remains a gap in efficiently generating novel AMPs across various amino acid lengths without prior knowledge of peptide structures or sequence alignments. Here we introduce ProT-Diff, a modularized and efficient deep generative approach that ingeniously combines a pre-trained protein language model with a diffusion model to de novo generate candidate AMP sequences. ProT-Diff enabled the rapid generation of thousands of AMPs with diverse lengths within hours. Following in silico screening based on physicochemical properties and predicted antimicrobial activities, we selected 35 peptides for experimental validation. Remarkably, 34 of these peptides demonstrated antimicrobial activity against Gram-positive or Gram-negative bacteria, with 6 exhibiting broad-spectrum efficacy. Of particular interest, AMP_2, one of the broad-spectrum peptides, displayed potent antimicrobial activity, low hemolysis, and minimal cytotoxicity. Further in vivo assessment revealed its high effectiveness against a clinically relevant drug-resistant E. coli strain in a mouse model of acute peritonitis. This study not only presents a viable generative strategy for novel AMP design but also underscores its potential for generating other functional peptides, thereby broadening the horizon for new drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2024.02.22.581480

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. De Oliveira, D.M.P. et al. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev 33 (2020). · DOI
  2. 10.1016/S0966-842X(00)01823-0 · DOI
  3. 2017, Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus, J Antibiot (Tokyo, 70, 142, 10.1038/ja.2016.101 · DOI
  4. 10.1074/jbc.M104925200 · DOI
  5. 10.1016/S0065-2164(04)54005-4 · DOI
  6. 10.1128/AAC.18.3.416 · DOI
  7. Bin Hafeez, A. , Jiang, X. , Bergen, P.J. & Zhu, Y. Antimicrobial peptides: an update on classifications and databases. Int J Mol Sci 22 (2021). · DOI
  8. 10.1038/nrmicro2745 · DOI
  9. 2020, Antimicrobial peptides as therapeutic agents: opportunities and challenges, Crit Rev Biotechnol, 40, 978, 10.1080/07388551.2020.1796576 · DOI
  10. 2022, Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds, J Appl Microbiol, 132, 1573, 10.1111/jam.15314 · DOI
  11. 10.1038/nbt1113 · DOI
  12. 10.1016/j.cell.2017.12.009 · DOI
  13. 2022, Identification of antimicrobial peptides from the human gut microbiome using deep learning, Nat Biotechnol, 40, 921, 10.1038/s41587-022-01226-0 · DOI
  14. 2020, Variational autoencoder for generation of antimicrobial peptides, ACS Omega, 5, 20746, 10.1021/acsomega.0c00442 · DOI
  15. 2021, Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations, Nat Biomed Eng, 5, 613, 10.1038/s41551-021-00689-x · DOI
  16. 10.3389/fmicb.2021.725727 · DOI
  17. 2023, Discovering highly potent antimicrobial peptides with deep generative model HydrAMP, Nat Commun, 14, 1453, 10.1038/s41467-023-36994-z · DOI · Paper page
  18. Robert, V. et al. Language models generalize beyond natural proteins. Preprint at https://www.biorxiv.org/content/10.1101/2022.1112.1121.521521v521521 (2022). · DOI
  19. 2021, Learning the protein language: Evolution, structure, and function, Cell Syst, 12, 654, 10.1016/j.cels.2021.05.017 · DOI · Paper page
  20. Hie, B.L. et al. Efficient evolution of human antibodies from general protein language models. Nat Biotechnol (2023). · DOI
  21. 10.1126/science.ade2574 · DOI · Paper page
  22. 10.1038/s41467-022-32007-7 · DOI · Paper page
  23. 2022, ProtTrans: Toward understanding the language of life through self-supervised learning, IEEE Trans Pattern Anal Mach Intell, 44, 7112, 10.1109/TPAMI.2021.3095381 · DOI · Paper page
  24. 2021, Diffusion models beat gans on image synthesis, Adv Neural Inf Process Syst, 34, 8780
  25. 10.48550/ARXIV.2006.11239 · DOI · Paper page
  26. Song, Y. & Ermon, S . Generative modeling by estimating gradients of the data distribution. Adv Neural Inf Process Syst 32 (2019).
  27. He, Z. , Sun, T. , Wang, K. , Huang, X. & Qiu, X. Diffusionbert: Improving generative masked language models with diffusion models. Preprint at https://arxiv.org/abs/2211.15029 (2022). · DOI
  28. Gong, S. , Li, M. , Feng, J. , Wu, Z. & Kong, L. Diffuseq: Sequence to sequence text generation with diffusion models. Preprint at https://arxiv.org/abs/2210.08933 (2022). · arXiv
  29. 2022, Diffusion-lm improves controllable text generation, Adv Neural Inf Process Syst, 35, 4328
  30. Lovelace, J. , Kishore, V. , Wan, C. , Shekhtman, E. & Weinberger, K. Latent diffusion for language generation. Preprint at https://arxiv.org/abs/2212.09462 (2022). · arXiv
  31. Kumar, P. , Kizhakkedathu, J.N. & Straus, S.K . Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules 8 (2018). · DOI
  32. 10.1016/j.resmic.2011.02.005 · DOI · Paper page
  33. Jacob, W. & Zack, W. Deep learning regression model for antimicrobial peptide design. Preprint at https://www.biorxiv.org/content/10.1101/692681v692681 (2019). · DOI
  34. Lazzaro, B.P. , Zasloff, M. & Rolff, J . Antimicrobial peptides: Application informed by evolution. Science 368 (2020). · DOI
  35. 10.1007/s11095-019-2745-x · DOI
  36. 10.1016/j.peptides.2003.07.025 · DOI
  37. 2021, Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis, J Antimicrob Chemother, 77, 155, 10.1093/jac/dkab378 · DOI
  38. Chosidow, S. et al. Synergistic activity of Pep16, a promising new antibacterial pseudopeptide against multidrug-resistant organisms, in combination with colistin against multidrug-resistant Escherichia coli, in vitro and in a murine peritonitis model. Antibiotics (Basel ) 12 (2023). · DOI
  39. 2023, Diffusion models: A comprehensive survey of methods and applications, ACM Comput Surv, 56, 1
  40. Wang, C. , Garlick, S. & Zloh, M . Deep learning for novel antimicrobial peptide design. Biomolecules 11 (2021). · DOI
  41. 10.1074/jbc.M408881200 · DOI
  42. 10.1016/j.bpj.2017.10.046 · DOI
  43. 10.1016/j.micpath.2017.09.046 · DOI
  44. 2021, In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria, BMC Pharmacol Toxicol, 22, 42, 10.1186/s40360-021-00503-z · DOI
  45. 10.1016/S0014-5793(99)00328-2 · DOI
  46. 10.1126/science.abj8754 · DOI · Paper page
  47. 10.1038/s41467-023-38328-5 · DOI · Paper page
  48. 10.1126/science.add2187 · DOI · Paper page
  49. Watson, J.L. et al. De novo design of protein structure and function with RFdiffusion. Nature (2023). · DOI · Paper page
  50. 10.1038/s41586-023-05696-3 · DOI
  51. 10.1038/s41586-018-0509-0 · DOI · Paper page
  52. 10.1093/NAR/GKAC933 · DOI
  53. 2015, A large-scale structural classification of antimicrobial peptides, Biomed Res Int, 2015, 475062
  54. 10.1093/nar/gkv1278 · DOI
  55. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition. CLSI document M02-A11 (2012).

Metadata

Authors
Wang, X.-F., Tang, J.-Y., Liang, H., Sun, J., Dorje, S., Peng, B., Ji, X.-W., Li, Z., Zhang, X.-E., & Wang, D.-B.
Affiliations
Chinese Academy of Sciences (CN)
Corresponding author
  • Li, Zhe
  • Zhang, Xian-En
  • Wang, Dian-Bing
Venue
Advanced Science
Publisher
openRxiv
Published
2024-02-23
Volume
11
Issue
43
Pages
e2406305-e2406305
ISSN
2198-3844 (ISSN-L)
OpenAlex
W4402841143
Cited by
55
References
1
Citations by year
2026: 28 · 2025: 24 · 2024: 3
FWCI
14.34
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Advanced Science (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (32271489)
  • National Key Research and Development Program of China (2022YFC2303501, 2018YFA0902702)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords
antimicrobial peptides, protein language models, diffusion models, antibiotic resistance, Escherichia coli, peritonitis, hemolysis, cytotoxicity
MeSH terms
Antimicrobial Peptides, Animals, Anti-Bacterial Agents, Disease Models, Animal, Escherichia coli, Gram-Negative Bacteria, Humans, Microbial Sensitivity Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review